Experiences of robot assisted thrombectomy with 2-year follow-up.
inferior vena cava
renal vein
robot
thrombectomy
Journal
The international journal of medical robotics + computer assisted surgery : MRCAS
ISSN: 1478-596X
Titre abrégé: Int J Med Robot
Pays: England
ID NLM: 101250764
Informations de publication
Date de publication:
22 Dec 2023
22 Dec 2023
Historique:
revised:
12
11
2023
received:
08
10
2023
accepted:
05
12
2023
medline:
22
12
2023
pubmed:
22
12
2023
entrez:
22
12
2023
Statut:
aheadofprint
Résumé
No consensus has been reached on operative procedures since a limited case series of robot-assisted inferior vena cava thrombectomy (RA-IVCT) and robot-assisted radical nephrectomy (RA-RN) have been described. The clinical data of 21 patients who underwent RA-IVCT and RA-RN were retrieved from the database. Preoperative preparation was used for assessment of the tumour. Surgical procedures were recorded, and operative skills were summarised. The median IVC clamping time was 23 min, and IVC wall invasion was pathologically found in 2 cases. The mean postoperative hospital stay was 8.4 days and most patients recovered to full ambulation and oral feeding on the fourth day. None of the patients had liver or kidney dysfunction at the last follow-up (median, 24 months). RA-IVCT presents technical challenges to surgeons. IVC control is an important part of the surgical process and different sides require different techniques.
Sections du résumé
BACKGROUND
BACKGROUND
No consensus has been reached on operative procedures since a limited case series of robot-assisted inferior vena cava thrombectomy (RA-IVCT) and robot-assisted radical nephrectomy (RA-RN) have been described.
METHODS
METHODS
The clinical data of 21 patients who underwent RA-IVCT and RA-RN were retrieved from the database. Preoperative preparation was used for assessment of the tumour. Surgical procedures were recorded, and operative skills were summarised.
RESULTS
RESULTS
The median IVC clamping time was 23 min, and IVC wall invasion was pathologically found in 2 cases. The mean postoperative hospital stay was 8.4 days and most patients recovered to full ambulation and oral feeding on the fourth day. None of the patients had liver or kidney dysfunction at the last follow-up (median, 24 months).
CONCLUSION
CONCLUSIONS
RA-IVCT presents technical challenges to surgeons. IVC control is an important part of the surgical process and different sides require different techniques.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e2611Subventions
Organisme : Research and Development Plan in China
ID : 2017YFB1303100
Organisme : National Natural Science Foundation of China
ID : 82002704
Organisme : National Natural Science Foundation of China
ID : 81927807
Organisme : National Natural Science Foundation of China
ID : 81874090
Organisme : National Natural Science Foundation of China
ID : 81972630
Organisme : Individual Innovative Research Funding of Union Hospital
ID : 2019xhyn124
Informations de copyright
© 2023 John Wiley & Sons Ltd.
Références
Blute ML, Leibovich BC, Lohse CM, Cheville JC, Zincke H. The Mayo Clinic experience with surgical management, complications and outcome for patients with renal cell carcinoma and venous tumour thrombus. BJU Int. 2004;94(1):33-41. https://doi.org/10.1111/j.1464-410x.2004.04897.x
Abaza R. Initial series of robotic radical nephrectomy with vena caval tumor thrombectomy. Eur Urol. 2011;59(4):652-656. https://doi.org/10.1016/j.eururo.2010.08.038
Nesbitt JC, Soltero ER, Dinney CP, et al. Surgical management of renal cell carcinoma with inferior vena cava tumor thrombus. Ann Thorac Surg. 1997;63(6):1592-1600. https://doi.org/10.1016/s0003-4975(97)00329-9
Skinner DG, Pfister RF, Colvin R. Extension of renal cell carcinoma into the vena cava: the rationale for aggressive surgical management. J Urol. 1972;107(5):711-716. https://doi.org/10.1016/s0022-5347(17)61122-4
Prunty M, Bell S, Kutikov A, Bukavina L. Review of robotic-assisted radical nephrectomy with inferior vena cava thrombectomy in renal cell carcinoma. Curr Urol Rep. 2022;23(12):363-370. https://doi.org/10.1007/s11934-022-01120-x
Wang B, Li H, Ma X, et al. Robot-assisted laparoscopic inferior vena cava thrombectomy: different sides require different techniques. Eur Urol. 2016;69(6):1112-1119. https://doi.org/10.1016/j.eururo.2015.12.001
Shi T, Huang Q, Liu K, et al. Robot-assisted cavectomy versus thrombectomy for level II inferior vena cava thrombus: decision-making scheme and multi-institutional analysis. Eur Urol. 2020;78(4):592-602. https://doi.org/10.1016/j.eururo.2020.03.020
Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240(2):205-213. https://doi.org/10.1097/01.sla.0000133083.54934.ae
Amin MB, Greene FL, Edge SB, et al. The Eighth Edition AJCC Cancer Staging Manual: continuing to build a bridge from a population-based to a more “personalized” approach to cancer staging. CA A Cancer J Clin. 2017;67(2):93-99. https://doi.org/10.3322/caac.21388
Agha RA, Sohrabi C, Mathew G, et al. The PROCESS 2020 Guideline: Updating Consensus Preferred Reporting Of CasESeries in Surgery (PROCESS) Guidelines. Int J Surg. 2020;84:231-235. https://doi.org/10.1016/j.ijsu.2020.11.005
Cheng G, Ruan H, Yang C, et al. Robot-assisted laparoscopic retroperitoneal leiomyosarcoma resection with inferior vena cava graft replacement: a case report. Transl Androl Urol. 2021;10(5):2133-2139. https://doi.org/10.21037/tau-20-1523
Reese AC, Whitson JM, Meng MV. Natural history of untreated renal cell carcinoma with venous tumor thrombus. Urol Oncol. 2013;31(7):1305-1309. https://doi.org/10.1016/j.urolonc.2011.12.006
Gill IS, Metcalfe C, Abreu A, et al. Robotic level III inferior vena cava tumor thrombectomy: initial series. J Urol. 2015;194(4):929-938. https://doi.org/10.1016/j.juro.2015.03.119
Abaza R, Shabsigh A, Castle E, et al. Multi-institutional experience with robotic nephrectomy with inferior vena cava tumor thrombectomy. J Urol. 2016;195(4 Pt 1):865-871. https://doi.org/10.1016/j.juro.2015.09.094
Bratslavsky G, Cheng JS. Robotic-assisted radical nephrectomy with retrohepatic vena caval tumor thrombectomy (level III) combined with extended retroperitoneal lymph node dissection. Urology. 2015;86(6):1235-1240. https://doi.org/10.1016/j.urology.2015.05.042
Wang B, Li H, Huang Q, et al. Robot-assisted retrohepatic inferior vena cava thrombectomy: first or second porta hepatis as an important boundary landmark. Eur Urol. 2018;74(4):512-520. https://doi.org/10.1016/j.eururo.2017.11.017
Wang B, Huang Q, Liu K, et al. Robot-assisted level III-IV inferior vena cava thrombectomy: initial series with step-by-step procedures and 1-yr outcomes. Eur Urol. 2020;78(1):77-86. https://doi.org/10.1016/j.eururo.2019.04.019
Ng CS, Wood CG, Silverman PM, Tannir NM, Tamboli P, Sandler CM. Renal cell carcinoma: diagnosis, staging, and surveillance. AJR Am J Roentgenol. 2008;191(4):1220-1232. https://doi.org/10.2214/ajr.07.3568
Zhang J, Lefkowitz RA, Bach A. Imaging of kidney cancer. Radiologic Clin N Am. 2007;45(1):119-147. https://doi.org/10.1016/j.rcl.2006.10.011
Aslam Sohaib SA, Teh J, Nargund VH, Lumley JSP, Hendry WF, Reznek RH. Assessment of tumor invasion of the vena caval wall in renal cell carcinoma cases by magnetic resonance imaging. J Urol. 2002;167(3):1271-1275. https://doi.org/10.1016/s0022-5347(05)65280-9
Yoshidome H, Takeuchi D, Ito H, et al. Should the inferior vena cava be reconstructed after resection for malignant tumors? Am J Surg. 2005;189(4):419-424. https://doi.org/10.1016/j.amjsurg.2005.01.010
Abel EJ, Thompson RH, Margulis V, et al. Perioperative outcomes following surgical resection of renal cell carcinoma with inferior vena cava thrombus extending above the hepatic veins: a contemporary multicenter experience. Eur Urol. 2014;66(3):584-592. https://doi.org/10.1016/j.eururo.2013.10.029
Gulia A, Puri A, Byregowda S, Rekhi B, Laskar S, Shetty N. Inferior vena caval tumor thrombus in giant cell tumor of sacrum - an unusual complication treated with multimodality management. J Orthop Case Rep. 2015;5(4):54-56.
Schwartz MJ, Smith EB, Trost DW, Vaughan ED, Jr. Renal artery embolization: clinical indications and experience from over 100 cases. BJU Int. 2007;99(4):881-886. https://doi.org/10.1111/j.1464-410x.2006.06653.x
Ghoreifi A, Djaladat H. Surgical tips for inferior vena cava thrombectomy. Curr Urol Rep. 2020;21(12):51. https://doi.org/10.1007/s11934-020-01007-9
Chen K, Liu Z, Li Y, et al. Diagnosis and treatment strategies for intraoperative pulmonary embolism caused by renal tumor thrombus shedding. J Card Surg. 2022;37(11):3973-3983. https://doi.org/10.1111/jocs.16874
Grasso M, Blanco S, Segramora V, Grasso EC, Leni D, Conti GM. Optional caval filter in kidney cancer patients with tumor thrombus level I and II. Minerva urologica e nefrologica = Italian J urology Nephrol. 2018;70(1):74-78. https://doi.org/10.23736/s0393-2249.17.02867-3
Ciancio G, Manoharan M, Katkoori D, De Los Santos R, Soloway MS. Long-term survival in patients undergoing radical nephrectomy and inferior vena cava thrombectomy: single-center experience. Eur Urol. 2010;57(4):667-672. https://doi.org/10.1016/j.eururo.2009.06.009
Leibovich BC, Cheville JC, Lohse CM, et al. Cancer specific survival for patients with pT3 renal cell carcinoma-can the 2002 primary tumor classification be improved? J Urol. 2005;173(3):716-719. https://doi.org/10.1097/01.ju.0000151830.27750.d2